Walleye Trading LLC Beam Therapeutics Inc. Transaction History
Walleye Trading LLC
- $52.6 Billion
- Q2 2025
A detailed history of Walleye Trading LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Walleye Trading LLC holds 8,100 shares of BEAM stock, worth $202,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,100Holding current value
$202,581% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
95.6MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$250 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$243 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$221 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$191 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$121 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.76B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...